UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2017-07, Vol.28 (suppl_4), p.iv1-iv21

2017

Volltextzugriff (PDF)

Incidence of T790M mutation in (sequential) rebiopsies in EGFR -mutated NSCLC-patients

Lung cancer (Amsterdam, Netherlands), 2014-07, Vol.85 (1), p.19-24

2014

Volltextzugriff (PDF)

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2534-2544

2015

Volltextzugriff (PDF)

The arterial load in pulmonary hypertension

European respiratory review, 2010-09, Vol.19 (117), p.197-203

2010

Volltextzugriff (PDF)

Opposite Effects of Training in Rats With Stable and Progressive Pulmonary Hypertension

Circulation (New York, N.Y.), 2009-07, Vol.120 (1), p.42-49

2009

Volltextzugriff (PDF)

Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment

European journal of cancer (1990), 2011-11, Vol.47 (17), p.2603-2606

2011

Volltextzugriff (PDF)

Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach

EClinicalMedicine, 2021-02, Vol.32, p.100731-100731, Article 100731

2021

Volltextzugriff (PDF)

Nintedanib for the treatment of symptomatic radiation pneumonitis. A Case Report

Heliyon, 2024-07, Vol.10 (14), p.e34345, Article e34345

2024

Volltextzugriff (PDF)

Exhaled molecular profiles in the assessment of cystic fibrosis and primary ciliary dyskinesia

Journal of cystic fibrosis, 2013-09, Vol.12 (5), p.454-460

2013

Volltextzugriff (PDF)

MS 24.05 Possibility of Chemotherapy for GGO-Containing Tumors

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1723-S1723

Postmus, P.E.

2017

Volltextzugriff (PDF)

High-dose, weekly erlotinib is not an effective treatment in EGFR -mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib

European journal of cancer (1990), 2014-05, Vol.50 (7), p.1399-1401

2014

Volltextzugriff (PDF)

Screening for lung cancer, an ongoing debate

Annals of oncology, 2008-09, Vol.19 (suppl-7), p.vii25-vii27

Postmus, P. E

2008

Volltextzugriff (PDF)

Second-Line Chemotherapy in Relapsing or Refractory Non–Small-Cell Lung Cancer: A Review

Journal of clinical oncology, 2000-11, Vol.18 (21), p.3722-3730

2000

Volltextzugriff (PDF)

62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S28-S29

2017

Volltextzugriff (PDF)

245 Towards Prediction of Efficacy of Chemotherapy: a Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography

European journal of cancer (1990), 2012-11, Vol.48, p.75-76

2012

Volltextzugriff (PDF)

Chemotherapy for brain metastases of lung cancer: A review

Annals of oncology, 1999-07, Vol.10 (7), p.753-759

1999

Volltextzugriff (PDF)

Pulmonary Function Changes After Stereotactic Ablative Radiotherapy In 201 Patients With Stage I Non-small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S579-S579

2011

Volltextzugriff (PDF)

6IN SCLC CONSENSUS

Lung cancer (Amsterdam, Netherlands), 2011, Vol.71, p.S5-S5

2011

Volltextzugriff (PDF)

Compression of the Pulmonary Vein After Right-Sided Pneumonectomy

Circulation (New York, N.Y.), 2006-05, Vol.113 (18)

2006

Volltextzugriff (PDF)

Photodynamic therapy, Nd-YAG laser and electrocautery for treating early-stage intraluminal cancer: which to choose?

Lung cancer (Amsterdam, Netherlands), 2001, Vol.31 (1), p.31-36

2001

Volltextzugriff (PDF)

181P Ninety-day mortality following curative intent radiotherapy for stage I-III lung cancer in the Netherlands

ESMO open, 2024-03, Vol.9, p.102755, Article 102755

2024

Volltextzugriff (PDF)

Second-line chemotherapy and its evaluation in small cell lung cancer

Cancer treatment reviews, 1999-08, Vol.25 (4), p.199-206

1999

Volltextzugriff (PDF)

Prophylactic Cranial Irradiation (PCI) in Extensive Stage Small Cell Lung Cancer (ES-SCLC) (EORTC 22993-08993)

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S4-S4

2007

Volltextzugriff (PDF)

Afatinib dose intensity and clinical efficacy in advanced EGFR-mutated non-small cell lung cancer: UK multicentre real-life data

Annals of oncology, 2018-10, Vol.29, p.viii526-viii526

2018

Volltextzugriff (PDF)

1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer

Annals of oncology, 2011-09, Vol.22 (9), p.1973-1980

2011

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(136)

Publikationsform

Artikel
(139)
Tagungsberichte
(1)

Sprache

Englisch
(140)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(71)
Humans
(68)
Biological And Medical Sciences
(53)
Medical Sciences
(53)
Male
(44)
Female
(41)
Oncology
(41)
Adult
(34)
Middle Aged
(34)
Aged
(30)
Respiratory System
(28)
Lung Neoplasms - Drug Therapy
(27)
Pharmacology. Drug Treatments
(24)
Chemotherapy
(23)
Antineoplastic Agents
(22)
Pneumology
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(16)
Tumors Of The Respiratory System And Mediastinum
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Incidence of T790M mutation in (sequential) rebiopsies in EGFR -mutated NSCLC-patients

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study

The arterial load in pulmonary hypertension

Opposite Effects of Training in Rats With Stable and Progressive Pulmonary Hypertension

Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment

Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach

Nintedanib for the treatment of symptomatic radiation pneumonitis. A Case Report

Exhaled molecular profiles in the assessment of cystic fibrosis and primary ciliary dyskinesia

MS 24.05 Possibility of Chemotherapy for GGO-Containing Tumors

High-dose, weekly erlotinib is not an effective treatment in EGFR -mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib

Screening for lung cancer, an ongoing debate

Second-Line Chemotherapy in Relapsing or Refractory Non–Small-Cell Lung Cancer: A Review

62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England

245 Towards Prediction of Efficacy of Chemotherapy: a Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography

Chemotherapy for brain metastases of lung cancer: A review

Pulmonary Function Changes After Stereotactic Ablative Radiotherapy In 201 Patients With Stage I Non-small Cell Lung Cancer

6IN SCLC CONSENSUS

Compression of the Pulmonary Vein After Right-Sided Pneumonectomy

Photodynamic therapy, Nd-YAG laser and electrocautery for treating early-stage intraluminal cancer: which to choose?

181P Ninety-day mortality following curative intent radiotherapy for stage I-III lung cancer in the Netherlands

Second-line chemotherapy and its evaluation in small cell lung cancer

Prophylactic Cranial Irradiation (PCI) in Extensive Stage Small Cell Lung Cancer (ES-SCLC) (EORTC 22993-08993)

Afatinib dose intensity and clinical efficacy in advanced EGFR-mutated non-small cell lung cancer: UK multicentre real-life data

1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer

Suchergebnisse filtern